Loading...
MicroPort Scientific Corporation
MCRPF•PNK
Healthcare
Medical - Devices
$1.12
$0.00(0.00%)
MicroPort Scientific Corporation (MCRPF) Financial Performance & Income Statement Overview
Review MicroPort Scientific Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.45%
↑ 8.45%
Operating Income Growth
75.69%
↑ 75.69%
Net Income Growth
55.19%
↑ 55.19%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
-13.29%
↓ 13.29%
Gross Margin
55.46%
↑ 55.46%
Net Profit Margin
-20.76%
↓ 20.76%
ROE
-32.89%
↓ 32.89%
ROIC
-5.59%
↓ 5.59%
MicroPort Scientific Corporation (MCRPF) Income Statement & Financial Overview
Review MicroPort Scientific Corporation's (MCRPF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $472.36M | $558.70M | $468.63M | $234.06M |
| Cost of Revenue | $228.85M | $228.12M | $230.04M | $112.22M |
| Gross Profit | $243.51M | $330.58M | $238.60M | $121.84M |
| Gross Profit Ratio | $0.52 | $0.59 | $0.51 | $0.52 |
| R&D Expenses | $101.48M | $115.03M | $186.95M | $96.79M |
| SG&A Expenses | $243.11M | $239.94M | $273.71M | $135.47M |
| Operating Expenses | $206.71M | $367.38M | $460.66M | $311.30M |
| Total Costs & Expenses | $435.56M | $595.51M | $690.70M | $423.52M |
| Interest Income | $0.00 | $11.72M | $16.85M | $20.71M |
| Interest Expense | $0.00 | $49.55M | $58.89M | $0.00 |
| Depreciation & Amortization | $37.19M | $56.24M | $82.90M | $23.74M |
| EBITDA | -$65.91M | $20.61M | -$263.83M | -$84.54M |
| EBITDA Ratio | -$0.14 | $0.04 | -$0.30 | -$0.36 |
| Operating Income | $36.80M | -$36.80M | -$222.07M | -$108.28M |
| Operating Income Ratio | $0.08 | -$0.07 | -$0.47 | -$0.46 |
| Other Income/Expenses (Net) | -$175.15M | -$49.64M | -$183.51M | -$32.06M |
| Income Before Tax | -$138.34M | -$86.44M | -$405.58M | -$210.17M |
| Income Before Tax Ratio | -$0.29 | -$0.15 | -$0.87 | -$0.90 |
| Income Tax Expense | $23.44M | $20.23M | $8.91M | $4.45M |
| Net Income | -$117.21M | -$96.83M | -$315.36M | -$157.51M |
| Net Income Ratio | -$0.25 | -$0.17 | -$0.67 | -$0.67 |
| EPS | -$0.06 | -$0.06 | -$0.17 | -$0.09 |
| Diluted EPS | -$0.07 | -$0.05 | -$0.17 | -$0.09 |
| Weighted Avg Shares Outstanding | $1.80B | $1.72B | $1.83B | $1.78B |
| Weighted Avg Shares Outstanding (Diluted) | $1.83B | $1.83B | $1.83B | $1.83B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan